Buscar
Mostrando ítems 1-10 de 76
Enzimas aminopeptidase- P e dipeptidilaminopeptidase IV na metabolização pulmonar de cininas em ratos normotensos e espontaneamente hipertensos
(Universidade Federal de São Paulo (UNIFESP), 1992)
Anti-tumor necrosis factor-α therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis
(2005)
Objective. To assess the enzymatic activity and biochemical status of dipeptidyl peptidase IV (DPP IV), an enzyme that participates in the degradation of proinflammatory molecules, in sera from a group of patients with ...
SGLT-2 inhibitors for people with type 2 diabetes.
(Elsevier, 2019)
Evidence that sodium-glucose co-transporter-2 inhibitors (SGLT2i) can reduce cardiovascular risk—with trials showing reductions in cardiovascular death, myocardial infarction, and stroke—would suggest they have much to ...
Effects of Dipeptidyl-Peptidase 4 Inhibitor about Vascular Inflammation in a Metabolic Syndrome Model
(Public Library of Science, 2014-09)
Background: In this study, we used vidagliptin(V) to examine the role of the DDP-IV, incretin system component, in the activation of different molecular inflammatory cytokines, NF-kB and VCAM-1 to generate a microenvironment ...
Dipeptidyl peptidase IV inhibitor improves the salivary gland histology of spontaneously diabetic mice
(2013-07-01)
Objectives: The incretin-based therapy might be effective in patients possessing certain levels of preserved pancreatic beta-cells. However, doubts still exist regarding the efficacy of this atment in the recovery of tissues ...
Dipeptidyl peptidase IV inhibitor improves the salivary gland histology of spontaneously diabetic mice
(2013-07-01)
Objectives: The incretin-based therapy might be effective in patients possessing certain levels of preserved pancreatic beta-cells. However, doubts still exist regarding the efficacy of this atment in the recovery of tissues ...